244 related articles for article (PubMed ID: 6613921)
1. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
2. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
3. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of vindesine in patients with advanced breast cancer.
Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
[TBL] [Abstract][Full Text] [Related]
6. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
[TBL] [Abstract][Full Text] [Related]
7. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
[No Abstract] [Full Text] [Related]
8. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of IV vinflunine in patients with chemotherapy naive metastatic malignant melanoma.
Olver IN; Byrne MJ; Walpole E; Vorobiof D; Jacobs C; Maart K; Hewitt S; McAdam G; Pouget JC; Pinel MC
Eur J Cancer; 2007 Aug; 43(12):1829-32. PubMed ID: 17631996
[TBL] [Abstract][Full Text] [Related]
10. Vindesine in bronchogenic carcinoma: a phase II trial.
Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
[TBL] [Abstract][Full Text] [Related]
11. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
[TBL] [Abstract][Full Text] [Related]
13. Vindesine. A phase II trial in advanced breast cancer patients.
Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.
Stanley AJ; Kaprielian R; Retsas S
Anticancer Res; 1993; 13(1):31-2. PubMed ID: 8476226
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
[No Abstract] [Full Text] [Related]
17. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
[TBL] [Abstract][Full Text] [Related]
18. Treatment of esophageal cancer with vindesine: an open trial.
Bezwoda WR; Derman DP; Weaving A; Nissenbaum M
Cancer Treat Rep; 1984 May; 68(5):783-5. PubMed ID: 6722833
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.
Gralla RJ; Raphael BG; Golbey RB; Young CW
Cancer Treat Rep; 1979 Aug; 63(8):1343-6. PubMed ID: 225028
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vindesine in metastatic malignant melanoma.
Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
[No Abstract] [Full Text] [Related]
[Next] [New Search]